The global pharmaceutical fine chemicals market is expected to reach USD 153.7 billion by 2025, according to a new report by Grand View Research, Inc. Increasing demand for preventive healthcare is expected to be a major factor driving market growth. Utilization of pharmaceutical fine chemicals (PFCs) has increased on account of the increasing aging population across the globe.
Cardiovascular is anticipated to the fastest growing application segment over the over the next eight years growing at an estimated CAGR of 8.4%. The occurrence of cardiovascular disease is on the rise owing to the unhealthy lifestyle of human beings. According to the World Health Organization (WHO), cardiovascular diseases are considered to be the prime cause of fatalities across the globe. The organization also states that cardiovascular diseases caused the death of approximately 17.7 million people in the year 2015. This number approximately represented 31% of the total deaths in the year 2015.
Obesity and an unhealthy lifestyle are some of the most important factors which lead to the occurrence of various diseases such as cardiovascular, neurological, oncological, infectious diseases, metabolic system, diabetes, respiratory, gastrointestinal, and musculoskeletal disorders. Eating junk food, leading unhygienic lifestyle, irregular timetable and many other unhealthy habits lead to diseases amongst human beings. Studies also show that males have more chance of contracting diabetes as compared to females. All these factors combined are thus anticipated to propel the market growth over the forecast period.
To request a sample copy or view summary of this report, click the link below:
Further key findings from the report suggest:
The global pharmaceutical fine chemicals demand in terms of revenue was USD 78.2 billion in 2016 and is expected to grow at a CAGR of 7.9% from 2017 to 2025
Proprietary emerged as the largest type segment in 2016 and is estimated to generate revenue of USD 125.1 billion by 2025
Big molecules were the largest size segment in 2016 and is expected to grow at an estimated CAGR of 7.8% over the next eight years
Advanced intermediates is expected to be the fastest growing product segment over the forecast period growing at an estimated CAGR of 8.3%
Industry participants include Angelini Acraf S.p.A, Albermarle Corporation, Chemada Fine Chemicals, W.R. Grace & Co., and Kenko Corporation. These players have vertically integrated their operations to increase their market presence and thus gain competitive advantage in the market
Grand View Research has segmented the global pharmaceutical fine chemicals market on the basis of application, type, size, product, and region:
Pharmaceutical Fine Chemicals Application Outlook (Revenue, USD Billion, 2014 - 2025)
Pharmaceutical Fine Chemicals Type Outlook (Revenue, USD Billion, 2014 - 2025)
Pharmaceutical Fine Chemicals Size Outlook (Revenue, USD Billion, 2014 - 2025)
Pharmaceutical Fine Chemicals Product Outlook (Revenue, USD Billion, 2014 - 2025)
Basic building blocks
Pharmaceutical Fine Chemicals Regional Outlook (Revenue, USD Billion, 2014 - 2025)
Central & South America
Middle East & Africa
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.